Table 2.
n (%)1 | |
CR (best overall response) | 10 (5.1) |
PR | 87 (44.2) |
SD | 55 (27.9) |
CB (CR + PR + SD) | 152 (77.1) |
PD | 13 (6.6) |
No tumor assessment | 32 (16.2) |
Values reported as number of patients and, in parentheses, percentage on total number of patients. CB: Clinical benefit; CR: Complete response; ITT: Intention-to-treat; PD: Progressive disease; PR: Partial response; SD: Stable disease.